3.12 (-%)
As of Nov 01, 2024
Source:
Phio Pharmaceuticals Corp. is a clinical stage biotechnology company whose proprietary INTASY self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. We are developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body’s ability to fight cancer, without the need for specialized formulations or drug delivery systems.
Country | United States |
Headquarters | marlborough, massachusetts |
Phone Number | (508) 767-3861 |
Industry | manufacturing |
CEO | Robert J. Bitterman |
Website | www.phiopharma.com |